Safety of GlaxoSmithKline (GSK) Biologicals Hepatitis A Vaccine in Korean Population
Completed
- Conditions
- Hepatitis A
- Registration Number
- NCT00237991
- Lead Sponsor
- GlaxoSmithKline
- Brief Summary
GlaxoSmithKline Korea has submitted a registration file for its hepatitis A vaccine. The present study will collect clinical data in the local target population as per the requirement of Korean Food and Drugs administration (FDA).
- Detailed Description
All subjects will be administered one dose of the hepatitis A vaccine.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method